Home The Word Brain	My Amedeo FAQ Privacy About
	2049 Chinese The 20K Word Road to Mandarin Proficiency By B. S. Kamps et al.

Anemia

Free Subscription Articles published in Blood Retrieve available abstracts of 271 articles: HTML format

Single Articles

April 2024
1. DEZERN AE
   A way to "mimic" the pathophysiology of acquired SAA.
   Blood. 2024;143:1318-1320.
   PubMed    
   
   
   
2. GORDEUK VR
   Glad tidings and joy for children with SCA.
   Blood. 2024;143:1326-1327.
   PubMed    
   
   
   March 2024
3. MAJUMDER R, Mohammad MA
   Sickle cell anemia: hepatic macrophages to the rescue.
   Blood. 2024;143:1209-1210.
   PubMed    
   
   
   
4. SILVESTRI L
   Ironing erythroid cells takes FLG1 and ERFE to tango.
   Blood. 2024;143:1208-1209.
   PubMed    
   
   
   
5. SZER J
   C5 inhibition in PNH: still effective and safe.
   Blood. 2024;143:1064-1065.
   PubMed    
   
   
   
6. KELLY RJ, Holt M, Vidler J, Arnold LM, et al
   Treatment outcomes of complement protein C5 inhibition in 509 UK patients with paroxysmal nocturnal hemoglobinuria.
   Blood. 2024;143:1157-1166.
   PubMed     Abstract available
   
   
   
7. NOGUCHI CT
   Hemolysis impairs sickle cell erythropoiesis.
   Blood. 2024;143:947-949.
   PubMed    
   
   
   
8. BENZ EJ JR, Silberstein LE, Panepinto J
   "Treatment with curative intent": the emergence of genetic therapies for sickle cell anemia.
   Blood. 2024;143:967-970.
   PubMed     Abstract available
   
   
   
9. LIU W, Wu Y, Wei H, Ma J, et al
   Lactate administration improves laboratory parameters in murine models of iron overload.
   Blood. 2024;143:1045-1049.
   PubMed     Abstract available
   
   
   
10. HAN Y, Gao C, Liu Y, Zhang H, et al
    Hemolysis-driven IFNalpha production impairs erythropoiesis by negatively regulating EPO signaling in sickle cell disease.
    Blood. 2024;143:1018-1031.
    PubMed     Abstract available
    
    
    
11. COATES TD
    Higher hemoglobin is better in thalassemia.
    Blood. 2024;143:842-844.
    PubMed    
    
    
    
12. PAREKH DS, Eaton WA, Thein SL
    Recent developments in the use of pyruvate kinase activators as a new approach for treating sickle cell disease.
    Blood. 2024;143:866-871.
    PubMed     Abstract available
    
    
    
13. MUSALLAM KM, Barella S, Origa R, Ferrero GB, et al
    Pretransfusion hemoglobin level and mortality in adults with transfusion-dependent beta-thalassemia.
    Blood. 2024;143:930-932.
    PubMed    
    
    
    
14. SAHA A, Palchaudhuri R, Lanieri L, Hyzy S, et al
    Alloengraftment without significant toxicity or GVHD in CD45 antibody-drug conjugate conditioned Fanconi anemia mice.
    Blood. 2024 Mar 6:blood.2023023549. doi: 10.1182/blood.2023023549.
    PubMed     Abstract available
    
    
    February 2024
15. FOGERTY AE, Kuter DJ
    How I treat thrombocytopenia in pregnancy.
    Blood. 2024;143:747-756.
    PubMed     Abstract available
    
    
    
16. JAMES AH, Strouse JJ
    How I treat sickle cell disease in pregnancy.
    Blood. 2024;143:769-776.
    PubMed     Abstract available
    
    
    
17. ORTEL TL
    Introduction to a How I Treat series on hematologic complications in pregnancy.
    Blood. 2024;143:739-740.
    PubMed    
    
    
    
18. D'SA S, Vos JMI, Barcellini W, Wardecki M, et al
    Safety, tolerability, and activity of the active C1s antibody riliprubart in cold agglutinin disease: a phase 1b study.
    Blood. 2024;143:713-720.
    PubMed     Abstract available
    
    
    
19. NINGTYAS DC, Leitner F, Sohail H, Thong YL, et al
    Platelets mediate the clearance of senescent red blood cells by forming prophagocytic platelet-cell complexes.
    Blood. 2024;143:535-547.
    PubMed     Abstract available
    
    
    January 2024
20. BEN HAMZA A, Welters C, Stadler S, Bruggemann M, et al
    Virus-reactive T cells expanded in aplastic anemia eliminate hematopoietic progenitor cells by molecular mimicry.
    Blood. 2024 Jan 26:blood.2023023142. doi: 10.1182/blood.2023023142.
    PubMed     Abstract available
    
    
    
21. GUIZOUARN H
    Mechanosensation and lipid scrambling news.
    Blood. 2024;143:300-301.
    PubMed    
    
    
    
22. 
    Keith J, Christakopoulos GE, Fernandez AG, et al. Loss of miR-144/451 alleviates beta-thalassemia by stimulating ULK1-mediated autophagy of free alpha-globin. Blood. 2023;142(10):918-932.
    Blood. 2024;143:377.
    PubMed    
    
    
    
23. LIANG P, Zhang Y, Wan YCS, Ma S, et al
    Deciphering and disrupting PIEZO1-TMEM16F interplay in hereditary xerocytosis.
    Blood. 2024;143:357-369.
    PubMed     Abstract available
    
    
    
24. NAMAZZI R, Bond C, Conroy A, Datta D, et al
    Hydroxyurea reduces infections in children with sickle cell anemia in Uganda.
    Blood. 2024 Jan 3:blood.2023021575. doi: 10.1182/blood.2023021575.
    PubMed     Abstract available
    
    
    December 2023
25. HELLSTROM-LINDBERG ES, Kroger N
    Clinical decision-making and treatment of myelodysplastic syndromes.
    Blood. 2023;142:2268-2281.
    PubMed     Abstract available
    
    
    
26. SHI H, Gao L, Kirby N, Shao B, et al
    Clearance of VWF by hepatic macrophages is critical for the protective effect of ADAMTS13 in sickle cell anemia mice.
    Blood. 2023 Dec 24:blood.2023021583. doi: 10.1182/blood.2023021583.
    PubMed     Abstract available
    
    
    
27. SARDO U, Perrier P, Cormier K, Sotin M, et al
    The hepatokine FGL1 regulates hepcidin and iron metabolism during anemia in mice by antagonizing BMP signaling.
    Blood. 2023 Dec 24:blood.2023022724. doi: 10.1182/blood.2023022724.
    PubMed     Abstract available
    
    
    
28. ATAGA KI
    The challenge of clinical end points in sickle cell disease.
    Blood. 2023;142:2047-2054.
    PubMed     Abstract available
    
    
    November 2023
29. SPARKENBAUGH E, Little J
    Cold comfort in sickle cell disease.
    Blood. 2023;142:1854-1856.
    PubMed    
    
    
    
30. CAI J, Lee J
    Cold agglutinin syndrome with unexpected bone marrow CD5+ diffuse large B-cell lymphoma.
    Blood. 2023;142:1935.
    PubMed    
    
    
    
31. IVY ZK, Belcher JD, Khasabova IA, Chen C, et al
    Cold exposure induces vaso-occlusion and pain in sickle mice that depend on complement activation.
    Blood. 2023;142:1918-1927.
    PubMed     Abstract available
    
    
    
32. DENTON CC, Vodala S, Veluswamy S, Hofstra TC, et al
    Splenic iron decreases without change in volume or liver parameters during luspatercept therapy.
    Blood. 2023;142:1932-1934.
    PubMed     Abstract available
    
    
    October 2023
33. VAN DE KAR NCAJ, Wetzels JFM
    Narrowing the knowledge gap in atypical HUS.
    Blood. 2023;142:1334-1335.
    PubMed    
    
    
    
34. 
    C5 inhibition in aHUS.
    Blood. 2023;142:1406.
    PubMed    
    
    
    
35. BROCKLEBANK V, Walsh PR, Smith-Jackson K, Hallam TM, et al
    Atypical hemolytic uremic syndrome in the era of terminal complement inhibition: an observational cohort study.
    Blood. 2023;142:1371-1386.
    PubMed     Abstract available
    
    
    
36. 
    d'Humieres T, Saba J, Savale L, et al. Determinants of ventricular arrhythmias in sickle cell anemia: toward better prevention of sudden cardiac death. Blood. 2023;142(5):409-420.
    Blood. 2023;142:1329.
    PubMed    
    
    
    
37. WU Z, Young NS
    Single-cell genomics in acquired bone marrow failure syndromes.
    Blood. 2023;142:1193-1207.
    PubMed     Abstract available
    
    
    September 2023
38. SALIBA AN, Musallam KM, Taher AT
    How I treat non-transfusion-dependent beta-thalassemia.
    Blood. 2023;142:949-960.
    PubMed     Abstract available
    
    
    
39. BABBS C
    The incredible ULK improves beta-thalassemia.
    Blood. 2023;142:862-863.
    PubMed    
    
    
    
40. KEITH J, Christakopoulos GE, Fernandez AG, Yao Y, et al
    Loss of miR-144/451 alleviates beta-thalassemia by stimulating ULK1-mediated autophagy of free alpha-globin.
    Blood. 2023;142:918-932.
    PubMed     Abstract available
    
    
    August 2023
41. GODLEY LA
    Germ line risk variants: beyond cancer.
    Blood. 2023;142:616-617.
    PubMed    
    
    
    
42. MOLTENI E, Bono E, Galli A, Elena C, et al
    Prevalence and clinical expression of germ line predisposition to myeloid neoplasms in adults with marrow hypocellularity.
    Blood. 2023;142:643-657.
    PubMed     Abstract available
    
    
    
43. JAVA A, Atkinson J, Hu Z, Pozzi N, et al
    Mutations in atypical hemolytic uremic syndrome provide evidence for the role of calcium in complement factor I.
    Blood. 2023;142:607-610.
    PubMed     Abstract available
    
    
    
44. DESAI AA
    Ventricular arrhythmias in sickle cell anemia.
    Blood. 2023;142:399-400.
    PubMed    
    
    
    July 2023
45. XI C, Pang J, Zhi W, Chang CS, et al
    Nrf2 sensitizes ferroptosis through l-2-hydroxyglutarate-mediated chromatin modifications in sickle cell disease.
    Blood. 2023;142:382-396.
    PubMed     Abstract available
    
    
    
46. TUBMAN VN, Mohandas N, Abrams CS
    New ASH initiatives to improve patient care in the long-overlooked sickle cell disease.
    Blood. 2023;142:230-234.
    PubMed     Abstract available
    
    
    
47. SIMONEAU J, Shah YM
    Ironing out beta-thalassemia during pregnancy.
    Blood. 2023;142:128-129.
    PubMed    
    
    
    
48. YU Y, Woloshun RR, Lee JK, Ebea PO, et al
    Fetal factors disrupt placental and maternal iron homeostasis in murine beta-thalassemia.
    Blood. 2023;142:185-196.
    PubMed     Abstract available
    
    
    June 2023
49. BRAMMER JE, Ballen K, Sokol L, Querfeld C, et al
    Effective Treatment with the Selective Cytokine Inhibitor BNZ-1 Reveals the Cytokine Dependency of T-LGL Leukemia.
    Blood. 2023 Jun 23:blood.2022017643. doi: 10.1182/blood.2022017643.
    PubMed     Abstract available
    
    
    
50. DEEG HJ
    Reward from half a match.
    Blood. 2023;141:3009-3010.
    PubMed    
    
    
    
51. TOLOSANO E
    Heme and macrophages: a complicated liaison.
    Blood. 2023;141:3015-3017.
    PubMed    
    
    
    
52. FERRER-VICENS I, Ferguson DCJ, Wilson MC, Heesom KJ, et al
    A novel human cellular model of CDA IV enables comprehensive analysis revealing the molecular basis of the disease phenotype.
    Blood. 2023;141:3039-3054.
    PubMed     Abstract available
    
    
    
53. SHARMA R, Antypiuk A, Vance SZ, Manwani D, et al
    Macrophage metabolic rewiring improves heme-suppressed efferocytosis and tissue damage in sickle cell disease.
    Blood. 2023;141:3091-3108.
    PubMed     Abstract available
    
    
    
54. LAM WK, Yip SF
    Cytopenic AML with marrow fibrosis and multihit TP53 abnormalities.
    Blood. 2023;141:3006.
    PubMed    
    
    
    
55. DEAN A
    Help on the way to unsilence HbF.
    Blood. 2023;141:2670-2672.
    PubMed    
    
    
    
56. DEAN A
    Help on the way to unsilence HbF.
    Blood. 2023;141:2670-2672.
    PubMed    
    
    
    May 2023
57. BENJAMIN RJ
    Cytosolic antigens prime RBC alloantibodies.
    Blood. 2023;141:2550-2551.
    PubMed    
    
    
    
58. D'HUMIERES T, Saba J, Savale L, Dupuy M, et al
    Determinants of Ventricular Arrhythmias in Sickle Cell Anemia: Towards a Better Prevention of Sudden Cardiac Death.
    Blood. 2023 May 22:blood.2022019571. doi: 10.1182/blood.2022019571.
    PubMed     Abstract available
    
    
    
59. HESLOP HE
    Introduction to a How I Treat series on emergent CAR T-cell toxicities.
    Blood. 2023;141:2405-2407.
    PubMed    
    
    
    April 2023
60. LI C, Georgakopoulou A, Newby GA, Chen PJ, et al
    In vivo HSC prime editing rescues sickle cell disease in a mouse model.
    Blood. 2023;141:2085-2099.
    PubMed     Abstract available
    
    
    
61. GUTIERREZ-RODRIGUES F, Munger E, Ma X, Groarke EM, et al
    Differential diagnosis of bone marrow failure syndromes guided by machine learning.
    Blood. 2023;141:2100-2113.
    PubMed     Abstract available
    
    
    
62. DEZERN A, Zahurak ML, Symons HJ, Cooke KR, et al
    Alternative donor BMT with post-transplant cyclophosphamide as initial therapy for acquired severe aplastic anemia.
    Blood. 2023 Apr 21:blood.2023020435. doi: 10.1182/blood.2023020435.
    PubMed     Abstract available
    
    
    
63. LANGER AL
    Love's labor's lost? Fetal vs maternal AIHA outcomes.
    Blood. 2023;141:1906-1907.
    PubMed    
    
    
    
64. GURNARI C, Prata PH, Catto LFB, Durmaz A, et al
    IPSS-M in myelodysplastic neoplasms arising from aplastic anemia and paroxysmal nocturnal hemoglobinuria.
    Blood. 2023 Apr 13:blood.2023020108. doi: 10.1182/blood.2023020108.
    PubMed    
    
    
    
65. SHET AS
    FXII and sickle cell: the clot thickens.
    Blood. 2023;141:1787-1789.
    PubMed    
    
    
    
66. RISITANO AM
    PNH and complement gene variants.
    Blood. 2023;141:1780-1782.
    PubMed    
    
    
    
67. SPARKENBAUGH EM, Henderson MW, Miller-Awe M, Abrams C, et al
    Factor XII contributes to thrombotic complications and vaso-occlusion in sickle cell disease.
    Blood. 2023;141:1871-1883.
    PubMed     Abstract available
    
    
    
68. PRATA PH, Galimard JE, Sicre de Fontbrune F, Duval A, et al
    Rare germline complement factor H variants in patients with paroxysmal nocturnal hemoglobinuria.
    Blood. 2023;141:1812-1816.
    PubMed     Abstract available
    
    
    
69. 
    Walter O, Cougoul P, Maquet J, et al. Risk of vaso-occlusive episode after exposure to corticosteroids in patients with sickle cell disease. Blood. 2022;139(26):3771-3777.
    Blood. 2023;141:1778.
    PubMed    
    
    
    March 2023
70. SUKUMAR S, Sasa G
    Blocking COX unlocks response in GHDD.
    Blood. 2023;141:1497-1498.
    PubMed    
    
    
    
71. BROWN TJ, Barrett N, Meng H, Ricciotti E, et al
    Nonsteroidal anti-inflammatory drugs as a targeted therapy for bone marrow failure in Ghosal hematodiaphyseal dysplasia.
    Blood. 2023;141:1553-1559.
    PubMed     Abstract available
    
    
    
72. ODAME I
    HU for SCA in Africa: associated malaria benefit.
    Blood. 2023;141:1370-1371.
    PubMed    
    
    
    
73. HAKKARAINEN M, Kaaja I, Douglas SPM, Vulliamy TJ, et al
    The Clinical Picture of the ERCC6L2 Disease - from Bone Marrow Failure to Acute Leukemia.
    Blood. 2023 Mar 23:blood.2022019425. doi: 10.1182/blood.2022019425.
    PubMed     Abstract available
    
    
    
74. HAMMOUDI N, Lionnet F
    Heart failure in SCA: still challenging.
    Blood. 2023;141:1248-1249.
    PubMed    
    
    
    
75. AYOUB PG, Kohn DB
    beta-Thalassemia: all about that base, no cutting.
    Blood. 2023;141:1098-1099.
    PubMed    
    
    
    
76. MATSON DR, Matkovic E
    Peripheral erythrophagocytosis in paroxysmal cold hemoglobinuria.
    Blood. 2023;141:1233.
    PubMed    
    
    
    
77. HARDOUIN G, Antoniou P, Martinucci P, Felix T, et al
    Adenine base editor-mediated correction of the common and severe IVS1-110 (G>A) beta-thalassemia mutation.
    Blood. 2023;141:1169-1179.
    PubMed     Abstract available
    
    
    
78. 
    Ludwig LS, Lareau CA, Bao EL, et al. Congenital anemia reveals distinct targeting mechanisms for master transcription factor GATA1. Blood. 2022;139(16):2534-2546.
    Blood. 2023;141:1094.
    PubMed    
    
    
    
79. FAKHOURI F, Schwotzer N, Fremeaux-Bacchi V
    How I diagnose and treat atypical hemolytic uremic syndrome.
    Blood. 2023;141:984-995.
    PubMed     Abstract available
    
    
    February 2023
80. OYEDEJI CI, Artz AS, Cohen HJ
    How I Treat Anemia in Older Adults.
    Blood. 2023 Feb 24:blood.2022017626. doi: 10.1182/blood.2022017626.
    PubMed     Abstract available
    
    
    
81. QUINN CT
    Hydroxyurea: how much is enough?
    Blood. 2023;141:813-814.
    PubMed    
    
    
    
82. 
    Camaschella C. Iron deficiency. Blood. 2019;133(1):30-39.
    Blood. 2023;141:682.
    PubMed    
    
    
    January 2023
83. FATTIZZO B, Bortolotti M, Fantini NN, Glenthoj A, et al
    AUTOIMMUNE HEMOLYTIC ANEMIA DURING PREGNANCY AND PUERPERIUM: AN INTERNATIONAL MULTI-CENTER EXPERIENCE.
    Blood. 2023 Jan 27:blood.2022018890. doi: 10.1182/blood.2022018890.
    PubMed     Abstract available
    
    
    
84. WOOD JC
    Anemia and brain hypoxia.
    Blood. 2023;141:327-328.
    PubMed    
    
    
    
85. 
    Barcellini W, Fattizzo B. How I treat warm autoimmune hemolytic anemia. Blood. 2021;137(10):1283-1294.
    Blood. 2023;141:438-439.
    PubMed    
    
    
    
86. PARROW NL, Fleming RE
    Transferrin receptor 1: keeper of HFE.
    Blood. 2023;141:332-333.
    PubMed    
    
    
    
87. TARFI S, Badaoui B
    Four genetic red cell disorders in one.
    Blood. 2023;141:436.
    PubMed    
    
    
    
88. XIAO X, Moschetta GA, Xu Y, Fisher AL, et al
    Regulation of iron homeostasis by hepatocyte TfR1 requires HFE and contributes to hepcidin suppression in beta-thalassemia.
    Blood. 2023;141:422-432.
    PubMed     Abstract available
    
    
    
89. BROUSSE V
    Ups and downs in the treatment of sickle cell disease.
    Blood. 2023;141:125-127.
    PubMed    
    
    
    
90. DAS NK, Shah YM
    (De)ironing out sickle cell disease.
    Blood. 2023;141:129-130.
    PubMed    
    
    
    
91. KARAMATIC CREW V, Tilley LA, Satchwell TJ, AlSubhi SA, et al
    Missense mutations in PIEZO1, which encodes the Piezo1 mechanosensor protein, define Er red blood cell antigens.
    Blood. 2023;141:135-146.
    PubMed     Abstract available
    
    
    
92. CURTIS SA, Novelli EM
    Is CBD ready for prime time in sickle cell disease?
    Blood. 2023;141:132-133.
    PubMed    
    
    
    
93. LI H, Kazmi JS, Lee S, Zhang D, et al
    Dietary iron restriction protects against vaso-occlusion and organ damage in murine sickle cell disease.
    Blood. 2023;141:194-199.
    PubMed     Abstract available
    
    
    
94. CHERUKURY HM, Argueta DA, Garcia N, Fouda R, et al
    Cannabidiol attenuates hyperalgesia in a mouse model of sickle cell disease.
    Blood. 2023;141:203-208.
    PubMed    
    
    
    
95. DAMPIER CD, Telen MJ, Wun T, Brown RC, et al
    A randomized clinical trial of the efficacy and safety of rivipansel for sickle cell vaso-occlusive crisis.
    Blood. 2023;141:168-179.
    PubMed     Abstract available
    
    
    
96. GROARKE EM, Feng X, Aggarwal N, Manley AL, et al
    Efficacy of JAK1/2 inhibition in murine immune bone marrow failure.
    Blood. 2023;141:72-89.
    PubMed     Abstract available
    
    
    
97. GRIFFIN M, Muus P, Munir T, Nagumantry S, et al
    Experience of compassionate-use pegcetacoplan for paroxysmal nocturnal hemoglobinuria.
    Blood. 2023;141:116-120.
    PubMed    
    
    
    December 2022
98. 
    Galli A, Todisco G, Catamo E, et al. Relationship between clone metrics and clinical outcome in clonal cytopenia. Blood. 2021;138(11):965-976.
    Blood. 2022;140:2858.
    PubMed    
    
    
    
99. SULLIVAN JC, Comenzo R
    Peripheral agglutination and hemolytic anemia following minor ABO-mismatch hematopoietic progenitor cell transplantation.
    Blood. 2022;140:2412.
    PubMed    
    
    
    November 2022
100. MORIN C, Sharma A, Selukar S, Beasley G, et al
     Diffuse Myocardial Fibrosis Occurs in Young Patients with Sickle Cell Anemia Despite Early Disease Modifying Therapy.
     Blood. 2022 Nov 28:blood.2022018209. doi: 10.1182/blood.2022018209.
     PubMed    
     
     
     
101. FLAUMENHAFT R
     Platelets: out of shape and misbehaving.
     Blood. 2022;140:2188-2190.
     PubMed    
     
     
     
102. KUTLAR A
     A-two to the rescue.
     Blood. 2022;140:2187-2188.
     PubMed    
     
     
     
103. ZHU J, Li H, Aerbajinai W, Kumkhaek C, et al
     Kruppel-like factor 1-GATA1 fusion protein improves the sickle cell disease phenotype in mice both in vitro and in vivo.
     Blood. 2022;140:2276-2289.
     PubMed     Abstract available
     
     
     
104. OLUPOT-OLUPOT P, Tomlinson G, Williams TN, Tshilolo LMM, et al
     Hydroxyurea is associated with lower malaria incidence in children with sickle cell anemia in sub-Saharan Africa.
     Blood. 2022 Nov 14. pii: 487110. doi: 10.1182/blood.2022017051.
     PubMed     Abstract available
     
     
     
105. LITTLE JA
     RBC, heal thyself: PK activators in SCD.
     Blood. 2022;140:2005-2006.
     PubMed    
     
     
     
106. XU JZ, Conrey A, Frey I, Gwaabe E, et al
     A phase 1 dose escalation study of the pyruvate kinase activator mitapivat (AG-348) in sickle cell disease.
     Blood. 2022;140:2053-2062.
     PubMed     Abstract available
     
     
     
107. GIBB DR, Hudson KE
     Sickle cell inflammation: is HbS the answer?
     Blood. 2022;140:1921-1923.
     PubMed    
     
     
     
108. ALLALI S, Rignault-Bricard R, de Montalembert M, Taylor M, et al
     HbS promotes TLR4-mediated monocyte activation and proinflammatory cytokine production in sickle cell disease.
     Blood. 2022;140:1972-1982.
     PubMed     Abstract available
     
     
     
109. ABDULLAHI S, Sunusi SM, Abba MS, Sani S, et al
     Hydroxyurea for Secondary Stroke Prevention in Children with Sickle Cell Anemia in Nigeria:a Randomized Controlled Trial.
     Blood. 2022 Nov 2. pii: 486968. doi: 10.1182/blood.2022016620.
     PubMed     Abstract available
     
     
     October 2022
110. CARSON JL, Brittenham GM
     How I Treat Anemia with Red Blood Cell Transfusion and Iron.
     Blood. 2022 Oct 31. pii: 486955. doi: 10.1182/blood.2022018521.
     PubMed     Abstract available
     
     
     
111. KHASABOVA II, Juliette J, Rogness VM, Khasabov SG, et al
     A model of painful vaso-occlusive crisis in mice with sickle cell disease.
     Blood. 2022;140:1826-1830.
     PubMed    
     
     
     
112. CARSETTI R, Agrati C, Pinto VM, Gianesin B, et al
     Premature aging of the immune system affects the response to SARS-CoV-2 mRNA vaccine in beta-thalassemia: role of an additional dose.
     Blood. 2022;140:1735-1738.
     PubMed    
     
     
     September 2022
113. PECKER LH, Ellsworth P
     Raise the roof, build the floor.
     Blood. 2022;140:1453-1455.
     PubMed    
     
     
     
114. HEENEY MM, Abboud MR, Githanga J, Inusa BPD, et al
     Ticagrelor vs placebo for the reduction of vaso-occlusive crises in pediatric sickle cell disease: the HESTIA3 study.
     Blood. 2022;140:1470-1481.
     PubMed     Abstract available
     
     
     
115. THEIN SL, Sachdev V
     Diffuse myocardial fibrosis as an SCD biomarker.
     Blood. 2022;140:1191-1192.
     PubMed    
     
     
     
116. 
     Tumburu L, Ghosh-Choudhary S, Seifuddin FT, et al. Circulating mitochondrial DNA is a proinflammatory DAMP in sickle cell disease. Blood. 2021;137(22):3116-3126.
     Blood. 2022;140:1327.
     PubMed    
     
     
     
117. TORRES LS, Hidalgo A
     NETs in sickle cell disease, quo vadis?
     Blood. 2022;140:938-939.
     PubMed    
     
     
     
118. CHONAT S, Stowell SR
     A virtuosic CADENZA played by sutimlimab.
     Blood. 2022;140:933-935.
     PubMed    
     
     
     
119. VATS R, Kaminski TW, Brzoska T, Leech JA, et al
     Liver-to-lung microembolic NETs promote gasdermin D-dependent inflammatory lung injury in sickle cell disease.
     Blood. 2022;140:1020-1037.
     PubMed     Abstract available
     
     
     
120. ROTH A, Berentsen S, Barcellini W, D'Sa S, et al
     Sutimlimab in patients with cold agglutinin disease: results of the randomized placebo-controlled phase 3 CADENZA trial.
     Blood. 2022;140:980-991.
     PubMed     Abstract available
     
     
     August 2022
121. HULBERT ML, Fields ME, Guilliams KP, Bijlani P, et al
     Normalization of cerebral hemodynamics following hematopoietic stem cell transplant in children with sickle cell disease.
     Blood. 2022 Aug 30. pii: 486449. doi: 10.1182/blood.2022016618.
     PubMed     Abstract available
     
     
     
122. DEZERN AE
     Playing with fire: unrecognized AA genetic predisposition.
     Blood. 2022;140:805-807.
     PubMed    
     
     
     
123. MARQUES O, Weiss G, Muckenthaler MU
     The role of iron in chronic inflammatory diseases - from mechanisms to treatment options in Anemia of Inflammation.
     Blood. 2022 Aug 22. pii: 486362. doi: 10.1182/blood.2021013472.
     PubMed     Abstract available
     
     
     
124. PARROW NL, Fleming RE
     Isn't it ironic: better RBCs by blocking iron.
     Blood. 2022;140:669-670.
     PubMed    
     
     
     
125. 
     Vats R, Kaminski TW, Ju E-M, et al. P-selectin deficiency promotes liver senescence in sickle cell disease mice. Blood. 2021;137(19):2676-2680.
     Blood. 2022;140:794.
     PubMed    
     
     
     
126. FATTIZZO B, Cecchi N, Bortolotti M, Giordano G, et al
     Thrombopoietin receptor agonists in adult Evans syndrome: an international multicenter experience.
     Blood. 2022;140:789-792.
     PubMed    
     
     
     
127. NYFFENEGGER N, Zennadi R, Kalleda N, Flace A, et al
     The oral ferroportin inhibitor vamifeport improves hemodynamics in a mouse model of sickle cell disease.
     Blood. 2022;140:769-781.
     PubMed     Abstract available
     
     
     
128. DOKAL I, Tummala H, Vulliamy T
     Inherited bone marrow failure in the pediatric patient.
     Blood. 2022;140:556-570.
     PubMed     Abstract available
     
     
     July 2022
129. PINCEZ T, Aladjidi N, Heritier S, Garnier N, et al
     Determinants of long-term outcomes of splenectomy in pediatric autoimmune cytopenias.
     Blood. 2022;140:253-261.
     PubMed     Abstract available
     
     
     
130. NISS O, Detterich JA, Wood JC, Coates TD, et al
     Early initiation of disease-modifying therapy can impede or prevent diffuse myocardial fibrosis in sickle cell anemia.
     Blood. 2022 Jul 20. pii: 485971. doi: 10.1182/blood.2021015303.
     PubMed    
     
     
     
131. MCREYNOLDS LJ, Rafati M, Wang Y, Ballew BJ, et al
     Genetic testing in severe aplastic anemia is required for optimal hematopoietic cell transplant outcomes.
     Blood. 2022 Jul 1. pii: 485762. doi: 10.1182/blood.2022016508.
     PubMed     Abstract available
     
     
     June 2022
132. LANZKRON S, Pecker L
     Pain without gain: steroids and sickle crisis.
     Blood. 2022;139:3678-3679.
     PubMed    
     
     
     
133. THAKRAL B, Bueso-Ramos CE
     Unexpected presentation of cold agglutinin syndrome with B-acute lymphoblastic leukemia.
     Blood. 2022;139:3778.
     PubMed    
     
     
     
134. WALTER O, Cougoul P, Maquet J, Bartolucci P, et al
     Risk of vaso-occlusive episode after exposure to corticosteroids in patients with sickle cell disease.
     Blood. 2022;139:3771-3777.
     PubMed     Abstract available
     
     
     
135. KROLL MH, Rojas-Hernandez C, Yee C
     Hematologic complications of immune checkpoint inhibitors.
     Blood. 2022;139:3594-3604.
     PubMed     Abstract available
     
     
     
136. GAVRIILAKI E, de Latour RP, Risitano AM
     Advancing therapeutic complement inhibition in hematologic diseases: PNH and beyond.
     Blood. 2022;139:3571-3582.
     PubMed     Abstract available
     
     
     
137. GERBER GF, Brodsky RA
     Pegcetacoplan for paroxysmal nocturnal hemoglobinuria.
     Blood. 2022;139:3361-3365.
     PubMed     Abstract available
     
     
     
138. DOTY RT, Fan X, Young DJ, Liang J, et al
     Studies of a mosaic patient with DBA and chimeric mice reveal erythroid cell-extrinsic contributions to erythropoiesis.
     Blood. 2022;139:3439-3449.
     PubMed     Abstract available
     
     
     May 2022
139. ISKANDER D, Warren AJ
     Turning up the HEAT(R3) in Diamond-Blackfan anemia.
     Blood. 2022;139:3101-3102.
     PubMed    
     
     
     
140. BODINE DM
     Anemia of inflammation is all the RAGE.
     Blood. 2022;139:3106-3107.
     PubMed    
     
     
     
141. XU JZ, Thein SL
     Revisiting anemia in sickle cell disease and finding the balance with therapeutic approaches.
     Blood. 2022;139:3030-3039.
     PubMed     Abstract available
     
     
     April 2022
142. NOVELLI EM
     Extinguishing the fire in sickle cell anemia.
     Blood. 2022;139:2578-2580.
     PubMed    
     
     
     
143. DAS NK, Jain C, Sankar A, Schwartz AJ, et al
     Modulation of the HIF2alpha-NCOA4 axis in enterocytes attenuates iron loading in a mouse model of hemochromatosis.
     Blood. 2022;139:2547-2552.
     PubMed     Abstract available
     
     
     
144. WHITE NJ
     What causes malaria anemia?
     Blood. 2022;139:2268-2269.
     PubMed    
     
     
     
145. MAHAMAR A, Gonzales Hurtado PA, Morrison R, Boone R, et al
     Plasma biomarkers of hemoglobin loss in Plasmodium falciparum-infected children identified by quantitative proteomics.
     Blood. 2022;139:2361-2376.
     PubMed     Abstract available
     
     
     
146. NWOGBO OV, Loghavi S
     Essential thrombocythemia complicating hemoglobin SC disease and presenting with priapism.
     Blood. 2022;139:2258.
     PubMed    
     
     
     
147. WANG M, Dingler FA, Patel KJ
     Genotoxic aldehydes in the hematopoietic system.
     Blood. 2022;139:2119-2129.
     PubMed     Abstract available
     
     
     
148. TOPFER SK, Feng R, Huang P, Ly LC, et al
     Disrupting the adult globin promoter alleviates promoter competition and reactivates fetal globin gene expression.
     Blood. 2022;139:2107-2118.
     PubMed     Abstract available
     
     
     March 2022
149. CAZZOLA M
     RNA missplicing and ring sideroblasts in MDS.
     Blood. 2022;139:1933-1935.
     PubMed    
     
     
     
150. WOOD JC
     Pulmonary hypertension in thalassemia: a call to action.
     Blood. 2022;139:1937-1938.
     PubMed    
     
     
     
151. PINTO VM, Musallam KM, Derchi G, Graziadei G, et al
     Mortality in beta-thalassemia patients with confirmed pulmonary arterial hypertension on right heart catheterization.
     Blood. 2022;139:2080-2083.
     PubMed    
     
     
     
152. SCHMIDT CQ, Schrezenmeier H, Kavanagh D
     Complement and the prothrombotic state.
     Blood. 2022;139:1954-1972.
     PubMed     Abstract available
     
     
     
153. DOSUNMU-OGUNBI A, Yuan S, Reynolds M, Giordano L, et al
     SOD2 V16A amplifies vascular dysfunction in sickle cell patients by curtailing mitochondria complex IV activity.
     Blood. 2022;139:1760-1765.
     PubMed     Abstract available
     
     
     
154. MESSONNIER LA
     Mitochondrial function in sickle cell disease.
     Blood. 2022;139:1616-1617.
     PubMed    
     
     
     
155. WONTAKAL SN, Britto M, Zhang H, Han Y, et al
     RACGAP1 variants in a sporadic case of CDA III implicate the dysfunction of centralspindlin as the basis of the disease.
     Blood. 2022;139:1413-1418.
     PubMed    
     
     
     February 2022
156. REES DC, Kilinc Y, Unal S, Dampier CD, et al
     A randomized, placebo-controlled, double-blind trial of canakinumab in children and young adults with sickle cell anemia.
     Blood. 2022 Feb 28. pii: 484189. doi: 10.1182/blood.2021013674.
     PubMed     Abstract available
     
     
     
157. O'DONOHUE MF, Da Costa LM, Lezzerini M, Unal S, et al
     HEATR3 variants impair nuclear import of uL18 (RPL5) and drive Diamond-Blackfan anemia.
     Blood. 2022 Feb 25. pii: 484180. doi: 10.1182/blood.2021011846.
     PubMed     Abstract available
     
     
     
158. GALLAGHER PG
     Anemia in the pediatric patient.
     Blood. 2022 Feb 25. pii: 484178. doi: 10.1182/blood.2020006479.
     PubMed     Abstract available
     
     
     
159. MENON AV, Liu J, Tsai HP, Zeng L, et al
     Excess heme upregulates heme oxygenase 1 and promotes cardiac ferroptosis in mice with sickle cell disease.
     Blood. 2022;139:936-941.
     PubMed     Abstract available
     
     
     January 2022
160. NEUMANN NM, Wen KW
     Myelodysplastic/myeloproliferative neoplasm with ring sideroblasts, thrombocytosis, and mutated JAK2/SF3B1 without anemia.
     Blood. 2022;139:466.
     PubMed    
     
     
     
161. RAO VK
     Evans syndrome: pathology and genomic hubris.
     Blood. 2022;139:312-313.
     PubMed    
     
     
     
162. KUMAR D, Prince C, Bennett CM, Briones M, et al
     T-follicular helper cell expansion and chronic T-cell activation are characteristic immune anomalies in Evans syndrome.
     Blood. 2022;139:369-383.
     PubMed     Abstract available
     
     
     
163. DULMOVITS BM, Tang Y, Papoin J, He M, et al
     HMGB1-Mediated Restriction of EPO Signaling Contributes to Anemia of Inflammation.
     Blood. 2022 Jan 18. pii: 483547. doi: 10.1182/blood.2021012048.
     PubMed     Abstract available
     
     
     
164. LUDWIG L, Lareau CA, Bao EL, Liu N, et al
     A Congenital Anemia Reveals Distinct Targeting Mechanisms for Master Transcription Factor GATA1.
     Blood. 2022 Jan 14. pii: 483530. doi: 10.1182/blood.2021013753.
     PubMed     Abstract available
     
     
     
165. DHUNPUTH C, Ducassou S, Fernandes H, Picard C, et al
     Abatacept is useful in autoimmune cytopenia with immunopathologic manifestations caused by CTLA-4 defects.
     Blood. 2022;139:300-304.
     PubMed    
     
     
     December 2021
166. PAGLIUCA S, Gurnari C, Awada H, Kishtagari A, et al
     The similarity of class II HLA genotypes defines patterns of autoreactivity in idiopathic bone marrow failure disorders.
     Blood. 2021;138:2781-2798.
     PubMed     Abstract available
     
     
     
167. TANG A, Strat AN, Rahman M, Zhang H, et al
     Murine bone marrow mesenchymal stromal cells have reduced hematopoietic maintenance ability in sickle cell disease.
     Blood. 2021;138:2570-2582.
     PubMed     Abstract available
     
     
     
168. PECKER L, Hussain S, Mahesh J, Varadhan R, et al
     Diminished ovarian reserve in young women with sickle cell anemia.
     Blood. 2021 Dec 5. pii: 482897. doi: 10.1182/blood.2021012756.
     PubMed    
     
     
     
169. MARTIN MERINERO H, Zhang Y, Arjona E, Del Angel G, et al
     Functional characterization of 105 factor H variants associated with aHUS: lessons for variant classification.
     Blood. 2021;138:2185-2201.
     PubMed     Abstract available
     
     
     November 2021
170. DUCHEMANN B, Lazarian G
     Post-SARS-CoV-2 vaccination acute hemolysis in an older man: don't forget to look at the blood smear.
     Blood. 2021;138:2153.
     PubMed    
     
     
     
171. PINCEZ T, Lee SSK, Ilboudo Y, Preuss M, et al
     Clonal hematopoiesis in sickle cell disease.
     Blood. 2021;138:2148-2152.
     PubMed    
     
     
     
172. LUZZATTO L
     Control of hemolysis in patients with PNH.
     Blood. 2021;138:1908-1910.
     PubMed    
     
     
     
173. KULASEKARARAJ AG, Risitano AM, Maciejewski JP, Notaro R, et al
     Phase 2 study of danicopan in patients with paroxysmal nocturnal hemoglobinuria with an inadequate response to eculizumab.
     Blood. 2021;138:1928-1938.
     PubMed     Abstract available
     
     
     
174. EL SISSY C, Saldman A, Zanetta G, Martins PV, et al
     COVID-19 as a potential trigger of complement-mediated atypical HUS.
     Blood. 2021;138:1777-1782.
     PubMed    
     
     
     
175. FENG Y, Feng W
     Numerous ring sideroblasts in chronic neutrophilic leukemia.
     Blood. 2021;138:1783.
     PubMed    
     
     
     
176. ZAIMOKU Y, Patel BA, Adams SD, Shalhoub RN, et al
     HLA associations, somatic loss of HLA expression, and clinical outcomes in immune aplastic anemia.
     Blood. 2021 Nov 1. pii: 477734. doi: 10.1182/blood.2021012895.
     PubMed     Abstract available
     
     
     September 2021
177. HENRY ER, Metaferia B, Li Q, Harper J, et al
     Treatment of sickle cell disease by increasing oxygen affinity of hemoglobin.
     Blood. 2021;138:1172-1181.
     PubMed     Abstract available
     
     
     
178. LIU Y, Pal M, Bao W, Shi PA, et al
     Type I interferon is induced by hemolysis and drives antibody-mediated erythrophagocytosis in sickle cell disease.
     Blood. 2021;138:1162-1171.
     PubMed     Abstract available
     
     
     
179. IRELAND RM, Rees DC
     Two brothers with a novel KLF1 mutation.
     Blood. 2021;138:1087.
     PubMed    
     
     
     
180. ABRAHAM AA, Tisdale JF
     Gene therapy for sickle cell disease: moving from the bench to the bedside.
     Blood. 2021;138:932-941.
     PubMed     Abstract available
     
     
     
181. BOLLARD CM
     Introduction to a review series on gene therapy and gene editing for sickle cell disease and hemophilia.
     Blood. 2021;138:913.
     PubMed    
     
     
     
182. PATEL BA, Groarke EM, Lotter J, Shalhoub RN, et al
     Long-term outcomes in severe aplastic anemia patients treated with immunosuppression and eltrombopag: a phase 2 study.
     Blood. 2021 Sep 15. pii: 476916. doi: 10.1182/blood.2021012130.
     PubMed     Abstract available
     
     
     August 2021
183. COCHRAN T, Li W
     Frequent internuclear bridging in a Fanconi anemia patient with FANCG mutation.
     Blood. 2021;138:738.
     PubMed    
     
     
     
184. XU Z, Mueller R
     Myelodysplastic pure red cell aplasia.
     Blood. 2021;138:500.
     PubMed    
     
     
     July 2021
185. JALINK M, Berentsen S, Castillo J, Treon SPP, et al
     Effect of ibrutinib treatment on hemolytic anemia and acrocyanosis in cold agglutinin disease/cold agglutinin syndrome.
     Blood. 2021 Jul 22. pii: 476451. doi: 10.1182/blood.2021012039.
     PubMed    
     
     
     
186. RICE L, Schwartz MR
     Sickle cell hepatopathy with spur cell anemia.
     Blood. 2021;138:283.
     PubMed    
     
     
     
187. GERBER GF, Yuan X, Yu J, Cher BAY, et al
     COVID-19 vaccines induce severe hemolysis in paroxysmal nocturnal hemoglobinuria.
     Blood. 2021;137:3670-3673.
     PubMed    
     
     
     June 2021
188. MORENO C
     Autoimmune cytopenia and CLL ride together.
     Blood. 2021;137:3464-3465.
     PubMed    
     
     
     
189. MARTIN MERINERO H, Subias M, Pereda A, Gomez-Rubio E, et al
     Molecular bases for the association of FHR-1 with atypical hemolytic uremic syndrome and other diseases.
     Blood. 2021;137:3484-3494.
     PubMed     Abstract available
     
     
     
190. REJESKI K, Perez Perez A, Sesques P, Hoster E, et al
     CAR-HEMATOTOX: A model for CAR T-cell related hematological toxicity in relapsed/refractory large B-cell lymphoma.
     Blood. 2021 Jun 24. pii: 476241. doi: 10.1182/blood.2020010543.
     PubMed     Abstract available
     
     
     
191. PSATHA N, Georgakopoulou A, Li C, Nandakumar V, et al
     Enhanced HbF reactivation by multiplex mutagenesis of thalassemic CD34+ cells in vitro and in vivo.
     Blood. 2021 Jun 4. pii: 476068. doi: 10.1182/blood.2020010020.
     PubMed     Abstract available
     
     
     
192. RARICK KR, Pritchard KA
     The sickle erythrocyte yields another DAMP.
     Blood. 2021;137:3010-3011.
     PubMed    
     
     
     
193. JONES RJ, DeBaun MR
     Leukemia after gene therapy for sickle cell disease: insertional mutagenesis, busulfan, both or neither.
     Blood. 2021 Jun 3. pii: 476065. doi: 10.1182/blood.2021011488.
     PubMed     Abstract available
     
     
     
194. TUMBURU L, Ghosh-Choudhary S, Seifuddin FT, Barbu EA, et al
     Circulating mitochondrial DNA is a proinflammatory DAMP in sickle cell disease.
     Blood. 2021;137:3116-3126.
     PubMed     Abstract available
     
     
     May 2021
195. RAB MAE, Bos J, van Oirschot BA, van Straaten S, et al
     Decreased activity and stability of pyruvate kinase in sickle cell disease: a novel target for mitapivat therapy.
     Blood. 2021;137:2997-3001.
     PubMed    
     
     
     
196. MANWANI D
     P-selectin and sickle cell disease: a balancing act.
     Blood. 2021;137:2573-2574.
     PubMed    
     
     
     
197. VATS R, Kaminski TW, Ju EM, Brozska T, et al
     P-selectin deficiency promotes liver senescence in sickle cell disease mice.
     Blood. 2021;137:2676-2680.
     PubMed     Abstract available
     
     
     
198. BRODSKY RA
     Eculizumab and aHUS: to stop or not.
     Blood. 2021;137:2419-2420.
     PubMed    
     
     
     
199. FAKHOURI F, Fila M, Hummel A, Ribes D, et al
     Eculizumab discontinuation in children and adults with atypical hemolytic-uremic syndrome: a prospective multicenter study.
     Blood. 2021;137:2438-2449.
     PubMed     Abstract available
     
     
     April 2021
200. CERCAMONDI CI, Stoffel N, Moretti D, Zoller T, et al
     Iron homeostasis during anemia of inflammation: a prospective study in patients with tuberculosis.
     Blood. 2021 Apr 19. pii: 475787. doi: 10.1182/blood.2020010562.
     PubMed     Abstract available
     
     
     
201. SHAH N
     ELIPSIS: developing tools to better understand VOC in SCD.
     Blood. 2021;137:1987-1988.
     PubMed    
     
     
     
202. GURNARI C, Maciejewski JP
     How I manage acquired pure red cell aplasia in adults.
     Blood. 2021;137:2001-2009.
     PubMed     Abstract available
     
     
     
203. PITTMAN DD, Hines PC, Beidler D, Rybin D, et al
     Evaluation of Longitudinal Pain Study in Sickle Cell Disease (ELIPSIS) by patient-reported outcomes, actigraphy, and biomarkers.
     Blood. 2021;137:2010-2020.
     PubMed     Abstract available
     
     
     
204. TURNIS ME, Kaminska E, Smith KH, Kartchner BJ, et al
     Requirement for antiapoptotic MCL-1 during early erythropoiesis.
     Blood. 2021;137:1945-1958.
     PubMed     Abstract available
     
     
     March 2021
205. GONG Y, Zhang X, Zhang Q, Zhang Y, et al
     A natural DNMT1 mutation elevates the fetal hemoglobin level via epigenetic derepression of the gamma-globin gene in beta-thalassemia.
     Blood. 2021;137:1652-1657.
     PubMed     Abstract available
     
     
     
206. ZHU C, Lian Y, Wang C, Wu P, et al
     Single-cell transcriptomics dissects hematopoietic cell destruction and T cell engagement in aplastic anemia.
     Blood. 2021 Mar 24. pii: 475591. doi: 10.1182/blood.2020008966.
     PubMed     Abstract available
     
     
     
207. HOSOKAWA K, Mizumaki H, Yoroidaka T, Maruyama H, et al
     HLA class I allele-lacking leukocytes predict rare clonal evolution to MDS/AML in patients with acquired aplastic anemia.
     Blood. 2021 Mar 22. pii: 475586. doi: 10.1182/blood.2020010586.
     PubMed    
     
     
     
208. BRUGNARA C
     Less (Fe) is more (Hb) in SCA.
     Blood. 2021;137:1446-1447.
     PubMed    
     
     
     
209. ANSARI J, Senchenkova EY, Vital SA, Al-Yafeai Z, et al
     Targeting the AnxA1/Fpr2/ALX pathway regulates neutrophil function, promoting thromboinflammation resolution in sickle cell disease.
     Blood. 2021;137:1538-1549.
     PubMed     Abstract available
     
     
     
210. ELDAR D, Ganzel C
     Erythrophagocytosis in a young adult with mycoplasma pneumonia-induced paroxysmal cold hemoglobinuria.
     Blood. 2021;137:1432.
     PubMed    
     
     
     
211. BERENTSEN S
     How I treat cold agglutinin disease.
     Blood. 2021;137:1295-1303.
     PubMed     Abstract available
     
     
     
212. BRODSKY RA
     How I treat paroxysmal nocturnal hemoglobinuria.
     Blood. 2021;137:1304-1309.
     PubMed     Abstract available
     
     
     
213. ZHABYEYEV P, Oudit GY
     Sickle cell disease, interleukin-18, and arrhythmias.
     Blood. 2021;137:1138-1139.
     PubMed    
     
     
     
214. GUPTA A, Fei YD, Kim TY, Xie A, et al
     IL-18 mediates sickle cell cardiomyopathy and ventricular arrhythmias.
     Blood. 2021;137:1208-1218.
     PubMed     Abstract available
     
     
     February 2021
215. WACHTER F, Archer NM
     Autoimmune hemolytic anemia complicated by parvovirus infection.
     Blood. 2021;137:1130.
     PubMed    
     
     
     
216. GU Y, Yang R, Yang Y, Zhao Y, et al
     IDH1 mutation contributes to myeloid dysplasia in mice by disturbing heme biosynthesis and erythropoiesis.
     Blood. 2021;137:945-958.
     PubMed     Abstract available
     
     
     
217. AL-SAMKARI H
     Hereditary hemorrhagic telangiectasia: systemic therapies, guidelines, and an evolving standard of care.
     Blood. 2021;137:888-895.
     PubMed     Abstract available
     
     
     
218. WARE RE, Dertinger SD
     There's safety in numbers.
     Blood. 2021;137:729-731.
     PubMed    
     
     
     
219. REES DC
     Hydroxyurea: coming to conclusions on safety.
     Blood. 2021;137:728-729.
     PubMed    
     
     
     
220. GILLE AS, Pondarre C, Dalle JH, Bernaudin F, et al
     Hydroxyurea does not affect the spermatogonial pool in prepubertal patients with sickle cell disease.
     Blood. 2021;137:856-859.
     PubMed    
     
     
     
221. JOSEPH L, Jean C, Manceau S, Chalas C, et al
     Effect of hydroxyurea exposure before puberty on sperm parameters in males with sickle cell disease.
     Blood. 2021;137:826-829.
     PubMed     Abstract available
     
     
     
222. SHENG Y, Ma R, Yu C, Wu Q, et al
     Role of c-Myc haploinsufficiency in the maintenance of HSCs in mice.
     Blood. 2021;137:610-623.
     PubMed     Abstract available
     
     
     January 2021
223. BADAT M, Davies JOJ, Fisher CA, Downes DJ, et al
     A remarkable case of HbH disease illustrates the relative contributions of the alpha-globin enhancers to gene expression.
     Blood. 2021;137:572-575.
     PubMed    
     
     
     
224. DEANS AJ
     Fanconi anemia, put to sleep.
     Blood. 2021;137:286-288.
     PubMed    
     
     
     
225. THOMAS M, Scully M
     How I Treat Microangiopathic Hemolytic Anemia in Patients with Cancer.
     Blood. 2021 Jan 21. pii: 475029. doi: 10.1182/blood.2019003810.
     PubMed     Abstract available
     
     
     
226. CAZZOLA M
     Introduction to a How I Treat Series on Acquired Hemolytic Anemia.
     Blood. 2021 Jan 21. pii: 475027. doi: 10.1182/blood.2020009747.
     PubMed    
     
     
     
227. BARCELLINI W, Fattizzo B
     How I treat warm autoimmune hemolytic anemia.
     Blood. 2021 Jan 21. pii: 475030. doi: 10.1182/blood.2019003808.
     PubMed     Abstract available
     
     
     
228. PIRENNE F
     Heme control to major B (cell): are you listening?
     Blood. 2021;137:153-154.
     PubMed    
     
     
     
229. PAL M, Bao W, Wang R, Liu Y, et al
     Hemolysis inhibits humoral B-cell responses and modulates alloimmunization risk in patients with sickle cell disease.
     Blood. 2021;137:269-280.
     PubMed     Abstract available
     
     
     
230. MU A, Hira A, Niwa A, Osawa M, et al
     Analysis of disease model iPSCs derived from patients with a novel Fanconi anemia-like IBMFS ADH5/ALDH2 deficiency.
     Blood. 2021 Jan 12. pii: 474923. doi: 10.1182/blood.2020009111.
     PubMed     Abstract available
     
     
     
231. SALIB C, Hussein S
     A case of hairy cell leukemia with markedly hypocellular marrow mimicking aplastic anemia.
     Blood. 2021;137:142.
     PubMed    
     
     
     December 2020
232. SICA M, Pellecchia A, De Angioletti M, Caocci G, et al
     Complement-mediated oxidative damage of red cells impairs response to eculizumab in a G6PD-deficient patient with PNH.
     Blood. 2020;136:3082-3085.
     PubMed    
     
     
     
233. MARIANI R, Liu H
     Severe transient pancytopenia with dyserythropoiesis and dysmegakaryopoiesis in COVID-19-associated MIS-C.
     Blood. 2020;136:2964.
     PubMed    
     
     
     
234. ARORA S, Ganapathi KA
     Prominent pseudo-Gaucher cells in a patient with beta-thalassemia intermedia and plasma cell myeloma.
     Blood. 2020;136:2839.
     PubMed    
     
     
     
235. PARROW NL, Violet PC, Ajit George N, Ali F, et al
     Dietary Iron Restriction Improves Markers of Disease Severity in Murine Sickle Cell Anemia.
     Blood. 2020 Dec 8. pii: 474426. doi: 10.1182/blood.2020006919.
     PubMed    
     
     
     November 2020
236. ABKOWITZ JL
     A simple Rx for congenital erythropoietic porphyria.
     Blood. 2020;136:2371-2372.
     PubMed    
     
     
     October 2020
237. DEWARRAT N, Blum S
     Heavy metal.
     Blood. 2020;136:1993.
     PubMed    
     
     
     September 2020
238. ARJONA E, Huerta A, Goicoechea de Jorge E, Rodriguez de Cordoba S, et al
     Familial risk of developing atypical hemolytic-uremic syndrome.
     Blood. 2020;136:1558-1561.
     PubMed    
     
     
     
239. KIM-SHAPIRO DB, Gladwin MT
     Arginine for mitochondrial oxidative enzymopathy.
     Blood. 2020;136:1376-1378.
     PubMed    
     
     
     
240. MORRIS CR, Brown LAS, Reynolds M, Dampier CD, et al
     Impact of arginine therapy on mitochondrial function in children with sickle cell disease during vaso-occlusive pain.
     Blood. 2020;136:1402-1406.
     PubMed     Abstract available
     
     
     
241. LUZZATTO L, Ally M, Notaro R
     Glucose-6-phosphate dehydrogenase deficiency.
     Blood. 2020;136:1225-1240.
     PubMed     Abstract available
     
     
     
242. SCHELL B, Fenneteau O
     Brandalise syndrome: a rare inclusion cell disease.
     Blood. 2020;136:1373.
     PubMed    
     
     
     
243. RISINGER M, Kalfa TA
     Red cell membrane disorders: structure meets function.
     Blood. 2020;136:1250-1261.
     PubMed     Abstract available
     
     
     
244. CAZZOLA M
     Introduction to a review series on inherited anemias.
     Blood. 2020;136:1215-1216.
     PubMed    
     
     
     
245. IOLASCON A, Andolfo I, Russo R
     Congenital dyserythropoietic anemias.
     Blood. 2020;136:1274-1283.
     PubMed     Abstract available
     
     
     
246. GRACE RF, Barcellini W
     Management of pyruvate kinase deficiency in children and adults.
     Blood. 2020;136:1241-1249.
     PubMed     Abstract available
     
     
     
247. BROUSSE V, Connes P
     Vasomotor hyperresponsiveness in SCD.
     Blood. 2020;136:1120-1121.
     PubMed    
     
     
     
248. VELUSWAMY S, Shah P, Khaleel M, Thuptimdang W, et al
     Progressive vasoconstriction with sequential thermal stimulation indicates vascular dysautonomia in sickle cell disease.
     Blood. 2020;136:1191-1200.
     PubMed     Abstract available
     
     
     August 2020
249. VOIT RA, Grace RF
     Pyruvate kinase deficiency in a newborn with extramedullary hematopoiesis in the skin.
     Blood. 2020;136:770.
     PubMed    
     
     
     July 2020
250. CARLESSO N
     Targeting the bone marrow niche in hemoglobinopathies.
     Blood. 2020;136:529-531.
     PubMed    
     
     
     
251. BRAZAUSKAS R, Scigliuolo GM, Wang HL, Cappelli B, et al
     Risk score to predict event-free survival after hematopoietic cell transplant for sickle cell disease.
     Blood. 2020;136:623-626.
     PubMed     Abstract available
     
     
     
252. ROTH A
     Do temperature and time matter in cold agglutinin disease?
     Blood. 2020;136:380-381.
     PubMed    
     
     
     
253. BERENTSEN S, Barcellini W, D'Sa S, Randen U, et al
     Cold agglutinin disease revisited: a multinational, observational study of 232 patients.
     Blood. 2020;136:480-488.
     PubMed     Abstract available
     
     
     
254. KATO GJ
     Sickle particulars of microparticles.
     Blood. 2020;136:154-155.
     PubMed    
     
     
     
255. GARNIER Y, Ferdinand S, Garnier M, Cita KC, et al
     Plasma microparticles of sickle patients during crisis or taking hydroxyurea modify endothelium inflammatory properties.
     Blood. 2020;136:247-256.
     PubMed     Abstract available
     
     
     
256. EVANS EL, Povstyan OV, De Vecchis D, Macrae F, et al
     RBCs prevent rapid PIEZO1 inactivation and expose slow deactivation as a mechanism of dehydrated hereditary stomatocytosis.
     Blood. 2020;136:140-144.
     PubMed    
     
     
     June 2020
257. KHAN R, Menard M, Jen CC, Chen X, et al
     Inhibition of platelet phagocytosis as an in vitro predictor for therapeutic potential of RBC antibodies in murine ITP.
     Blood. 2020;135:2420-2424.
     PubMed     Abstract available
     
     
     
258. CHEN BY, Song J, Hu CL, Chen SB, et al
     SETD2 deficiency accelerates MDS-associated leukemogenesis via S100a9 in NHD13 mice and predicts poor prognosis in MDS.
     Blood. 2020;135:2271-2285.
     PubMed     Abstract available
     
     
     
259. HUANG P, Peslak SA, Lan X, Khandros E, et al
     The HRI-regulated transcription factor ATF4 activates BCL11A transcription to silence fetal hemoglobin expression.
     Blood. 2020;135:2121-2132.
     PubMed     Abstract available
     
     
     
260. WALTERS MC
     Sickle marrow: double, double toil and trouble.
     Blood. 2020;135:2017-2018.
     PubMed    
     
     
     
261. PARK SY, Matte A, Jung Y, Ryu J, et al
     Pathologic angiogenesis in the bone marrow of humanized sickle cell mice is reversed by blood transfusion.
     Blood. 2020;135:2071-2084.
     PubMed     Abstract available
     
     
     May 2020
262. KHANDROS E, Huang P, Peslak SA, Sharma M, et al
     Understanding heterogeneity of fetal hemoglobin induction through comparative analysis of F and A erythroblasts.
     Blood. 2020;135:1957-1968.
     PubMed     Abstract available
     
     
     
263. GORDEUK VR
     Sickle cell vaso-occlusion: the clot thickens.
     Blood. 2020;135:1726-1727.
     PubMed    
     
     
     
264. SPARKENBAUGH EM, Chen C, Brzoska T, Nguyen J, et al
     Thrombin activation of PAR-1 contributes to microvascular stasis in mouse models of sickle cell disease.
     Blood. 2020;135:1783-1787.
     PubMed     Abstract available
     
     
     April 2020
265. SCHINDLER D, Kalb R
     Disease and mutation: correlations coming to fruition.
     Blood. 2020;135:1514-1515.
     PubMed    
     
     
     
266. APRILE A, Gulino A, Storto M, Villa I, et al
     Hematopoietic stem cell function in beta-thalassemia is impaired and is rescued by targeting the bone marrow niche.
     Blood. 2020 Apr 28. pii: 454666. doi: 10.1182/blood.2019002721.
     PubMed     Abstract available
     
     
     
267. GHANNAM JY, Xu X, Maric I, Dillon L, et al
     Baseline TP53 mutations in adults with SCD developing myeloid malignancy following hematopoietic cell transplantation.
     Blood. 2020;135:1185-1188.
     PubMed    
     
     
     March 2020
268. SARAF SL
     Heme A1M'ed at the kidney in sickle cell disease.
     Blood. 2020;135:979-981.
     PubMed    
     
     
     
269. OFORI-ACQUAH SF, Hazra R, Orikogbo OO, Crosby D, et al
     Hemopexin deficiency promotes acute kidney injury in sickle cell disease.
     Blood. 2020;135:1044-1048.
     PubMed     Abstract available
     
     
     
270. BRODSKY RA
     A complementary new drug for PNH.
     Blood. 2020;135:884-885.
     PubMed    
     
     
     
271. ROTH A, Nishimura JI, Nagy Z, Gaal-Weisinger J, et al
     The complement C5 inhibitor crovalimab in paroxysmal nocturnal hemoglobinuria.
     Blood. 2020;135:912-920.
     PubMed     Abstract available
     
     

Thank you for your interest in scientific medicine.

AMEDEO Anemia is free of charge.